Provides tools and resources for members to successfully litigate their cases. Group members network and discuss legal issues and strategies on the Group's plaintiff-only list server and at regular meetings, including AAJ Conventions and Education seminars.Join Litigation Group
SGLT2 Inhibitors are sodium-glucose transport protein inhibitors that block glucose from being absorbed by the kidneys and instead be excreted through urine. They are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. SGLT2 Inhibitors are not approved for the treatment of Type 1 diabetes mellitus.
Invokana was approved by the FDA in March 2013 and was the first SGLT2 Inhibitor to be marketed in the United States. It is manufactured and distributed by Janssen Pharmaceuticals, a wholly owned subsidiary of Johnson & Johnson. Invokana is the market leader of the SGLT2 Inhibitor class, has been a blockbuster drug since its introduction to the market and has continued to increase market share for treatment of Type 2 diabetes mellitus.
On May 15, 2015, the FDA announced that SGLT2 inhibitors may lead to ketoacidosis, a serious condition where the body produces high levels of blood acids called ketones. Ketoacidosis requires hospitalization and can cause fatal swelling of the brain known as cerebral edema, pulmonary edema, cardiac dysrhythmia, nonspecific myocardial injury, myocardial infarction, cerebrovascular accident, diabetic retinopathy, hypoglycemia, hypokalemia, severe dehydration, and coma.
The Group hosts meetings at the AAJ Annual and Winter Conventions and provides tools and resources for members to successfully litigate their cases. Group members network and discuss legal issues and strategies on the Group's plaintiff-only list server and at regular meetings, including AAJ Conventions and Education seminars.
Litigation Group members, visit AAJ's Community Center to connect with your colleagues, search discussion archives, download documents, update your list server settings, and more. Lit Group Member Login